Your body relies on the SLC1A1 gene to move glutamate and certain amino acids into cells, especially in the brain, kidneys, and gut. This helps support nerve signaling and protects cells from chemical stress. If the gene does not work properly, some people can have rare problems handling certain amino acids and may have changes that affect brain development or behavior. Many variants in this gene have little effect, while a few are linked to rare inherited conditions.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or regulate processes in the body. Some genes hold the information needed to make proteins, the working parts of cells. Others mainly help direct when certain processes happen, where they take place, and how strongly they run. Taken together, genes influence how the body develops and works, and they can shape how you respond to food, stress, or medications. To go into this topic in more depth, you can find more in the LearnHub.
Overview
SLC1A1Gene function
What if the gene works
The SLC1A1 gene helps cells move glutamate, a brain signaling chemical, and cysteine, a building block for antioxidant defenses, into the cell. This supports nerve signaling and helps protect cells from everyday stress.
Risk
What if the gene does not work
More severe variants in the SLC1A1 gene can cause a rare condition with developmental delay, seizures, and movement or behavior differences, often with excess acidic amino acids in the urine. Milder variants may have subtler effects.
Treatment
What does that mean for your treatment
No treatment or medication choice that is specific to a pathogenic or loss of function variant in the SLC1A1 gene is currently established in clinical guidelines. The SLC1A1 gene is being studied in early research as a possible drug target and biomarker in some brain conditions, but this has not changed routine care.
Conditions associated with SLC1A1
Gene function
What if the gene works
In the brain and a few other tissues, the SLC1A1 gene helps move certain amino acids into cells and keeps signaling balanced. Its protein acts like a gate in the cell membrane, especially for glutamate and cysteine. Understanding how the SLC1A1 gene supports glutamate transport in the brain helps show how nerve cells keep messages precise and steady.
The SLC1A1 gene helps cells take in glutamate from the space outside the cell. This keeps glutamate available for normal cell use and helps control how much remains near nerve endings.
In nerve cells, this protein clears glutamate after a message has been passed. That helps brain signals stay brief and better controlled instead of lingering longer than needed.
SLC1A1 also helps bring cysteine into cells. Cells use cysteine to make glutathione, a natural protector that helps manage oxidative stress (cell strain from normal energy use).
What is a variant?
A genetic variant is a minor difference in the DNA sequence within a gene. These differences are common and are part of normal human diversity, including differences in appearance, metabolism, or the way the body responds to environmental influences. Many variants do not have any noticeable effect and are simply part of natural genetic variation. Sometimes, though, a variant changes how a gene works more significantly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Many variants in the SLC1A1 gene alter the transporter’s shape, stability, or delivery to the cell surface, reducing glutamate and aspartate uptake. Some changes partly lower transport, while more disruptive variants can nearly abolish activity or prevent the protein from reaching the cell membrane. This is the main pattern behind how SLC1A1 gene variants affect protein function. With severe variants in both copies, linked features may appear earlier and be more marked than with milder changes.
How variants are linked to conditions
In discussions of SLC1A1 gene variants and related conditions, the best-established link is dicarboxylic aminoaciduria, a very rare inherited condition. It is usually diagnosed when both copies of the SLC1A1 gene carry pathogenic variants. Some people with this diagnosis also have developmental delay, seizures, or behavioral and movement differences, although the pattern can vary from person to person.
A variant is not necessarily a diagnosis
Genetic variants are common across the general population and are a normal feature of human biology. Most do not directly affect health and simply contribute to natural human diversity. For many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, particularly when more than one gene and environmental factors play a role. In contrast, there are situations in which one well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There isn't yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the SLC1A1 gene. Some changes in this gene have been studied in brain and kidney conditions, but risk can vary and is not defined by this gene alone.
Inheritance of SLC1A1 variants
For the established rare condition linked to this gene, the SLC1A1 inheritance pattern is autosomal recessive. This means a child usually needs to inherit one disease causing variant in the SLC1A1 gene from each parent to be affected, while parents with one variant are typically carriers. When both parents are carriers, each pregnancy has a 25% chance of an affected child, a 50% chance of a carrier child, and a 25% chance of a child with neither variant. Because the SLC1A1 gene is on chromosome 9, this pattern affects sons and daughters equally.
What does my SLC1A1 result mean for my family?
For the rare kidney-related condition linked to SLC1A1, the pattern is recessive, which means parents are usually healthy carriers and brothers or sisters may also be affected or be carriers. Close relatives may want to learn whether the same family variant is present, especially if there is a history of similar findings in the family.
Genetic information
Genetic testing
How you find out about variants
A genetic test for SLC1A1 variants usually uses a blood sample or cheek swab to read the DNA sequence of the SLC1A1 gene. Results may show whether you carry a variant, but a finding is interpreted alongside your symptoms, family history, and the lab’s evidence about that specific change.
When should I consider getting a genetic test?
There is not yet a broadly established reason to order SLC1A1 testing on its own. Decisions about testing are usually based on the full pattern of symptoms and family history, together with a doctor or genetic counselor.
A genetic result is only one part of your health story
A genetic result can provide valuable insight, but how much it explains depends on the condition and the type of variant involved. Over time, many factors, including lifestyle, environment, age, and medical history, influence how the body functions. In some conditions, especially those shaped by many genes, genetic information provides context rather than certainty and is most useful when considered together with other parts of care. In other situations, a genetic result may offer a clear answer. In areas like medication response, genetic results can also help put personal experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body absorbs, breaks down, moves, or responds to a drug. This is one reason the same medication may work well for one person but less well for another, or may cause more side effects in some people. These differences are common and can influence both how effective a treatment feels and how sensitive someone is to it.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences affect the way people respond to medications. It studies connections between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes influence both how strongly a drug works and how the body processes it. This information can support more informed, more individualized treatment decisions. If you want to learn more about this subject, you can explore it further in the LearnHub.
Drugs influenced by the SLC1A1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choices, so general questions about medicines, side effects, or treatment response are best discussed with your doctor. If a medicine is not helping as expected or is causing new problems, speak with your doctor or pharmacist before making any changes.
History
In the 1990s, researchers identified the SLC1A1 gene while mapping a family of glutamate transporter genes in the brain and other tissues. Building on this early work, scientists linked SLC1A1 to a rare inherited condition called dicarboxylic aminoaciduria, which helped confirm its medical relevance. In the 2000s, the gene also drew attention in studies of obsessive-compulsive disorder, although those findings have been more mixed and have evolved over time. Scientific classifications changed as researchers learned more about the gene, including its place among transport proteins once grouped mainly by lab behavior rather than by DNA sequence. These steps gradually moved SLC1A1 from a research finding to a recognized part of clinical genetics.